Tag: pharmaceuticals
-
Fixed-Dose Blood Pressure Drugs Shown Cost-Effective
An analysis of medical insurance claims shows fixed-dose combination drugs to be the most cost-effective medication strategy for people with hypertension, or high blood pressure.
-
Univ. Spin-Off Discovering New Antibiotics
A new enterprise founded by three microbiologists at Harvard Medical School is licensing the founders’ research to find treatments for antibiotic-resistant bacteria.
-
Bacteria Engineered to Act as Long-Term Gut Sensors
A bioengineering team developed a synthetic form of bacteria that live in the gut, and detect inflammation in lab mice for 6 months.
-
Report: Growing Tech Industry Investment in Health
The information technology industry is a growing presence in health care, both financially and qualitatively, according to a new report.
-
$10M Cancer Immunotherapy Research Fund Launched
A foundation is sponsoring research grants totaling $10 million for computational solutions to key questions facing cancer immunotherapy.
-
Bacteria Traffic Tracked in New Hospital
The opening of a new hospital in Chicago offered an opportunity to follow the formation of bacterial communities and their movement in a health care facility.
-
Chip Device Simulates Viral Asthma Attacks
A small plastic chip device that acts as a model of a human airway simulated a severe asthma exacerbation or attack caused by a viral infection.
-
Trial Begins of Freeze-Dried Blood Plasma
A clinical trial is underway testing the safety and practicality of using a person’s own freeze-dried blood plasma for transfusions, substituting for frozen or liquid plasma.
-
Personalized Drug Delivery System Demonstrated
Biomedical engineers developed and demonstrated in lab animals a closed-loop system that monitors and controls delivery of drugs to meet an individual’s personalized needs.
-
Sound Waves, Nanotech Delivery Boost Cancer Drug
Focused sound waves aimed at nanoscale bubbles filled with a cancer drug, were shown in lab mice to improve delivery of the drug to a particularly hard-to-treat cancer.